Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
---|---|---|---|
Dermata Therapeutics Inc | DRMA | NASDAQ | Acción Común |
Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
---|---|---|---|---|
0.33725 | 0.33 | 0.355 | 0.336 | 0.3401 |
Noticias Recientes
Fecha | Hora | Fuente | Noticia |
---|---|---|---|
12/1/2024 | 15:06 | EDGAR2 | Form 8-K - Current report |
05/1/2024 | 20:01 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
05/1/2024 | 20:00 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
05/1/2024 | 20:00 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
17/12/2023 | 23:15 | EDGAR2 | Form EFFECT - Notice of Effectiveness |
15/12/2023 | 16:00 | EDGAR2 | Form 424B3 - Prospectus [Rule 424(b)(3)] |
07/12/2023 | 15:05 | EDGAR2 | Form S-3 - Registration statement under Securities Act of.. |
09/11/2023 | 15:09 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
09/11/2023 | 15:08 | EDGAR2 | Form 8-K - Current report |
10/8/2023 | 15:18 | EDGAR2 | Form 8-K - Current report |
10/8/2023 | 15:16 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
03/8/2023 | 15:31 | EDGAR2 | Form 8-K - Current report |